tetracycline hydrochloride

PreclinicalSmall molecule

EEuropean Organisation for Research and Treatment of Cancer - EORTC

tetracycline hydrochloride is one of 28 small molecule programs targeting Breast Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Breast CancerActive, not recruiting

Skin RashActive, not recruiting

Breast CancerPreclinical

Active, not recruiting

Skin RashPreclinical

Active, not recruiting

Competition

Competitive Landscape

744 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Lexiscan

Astellas

Preclinical

1 2

Sporanox

SSebela Pharmaceuticals Development LLC

Preclinical

1 3

Vfend

PPrism Pharmaceuticals

Preclinical

—4

Ablavar

LLantheus Medical Imaging

Preclinical

2 5

Naltrexone/bupropion

Novo Nordisk

Preclinical

1 6

Sertraline ODT

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 7

Liposomal Irinotecan and Apatinib

SSecond Affiliated Hospital, School of Medicine, Zhejiang University

Preclinical

1 8

Ibrance

Pfizer

Preclinical

1 9

tetracycline hydrochloride

EEuropean Organisation for Research and Treatment of Cancer - EORTC

Preclinical

1 10

Fluorothymidine F-18

MM.D. Anderson Cancer Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Skin rash1 trial

Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer

Completed·AAlliance for Clinical Trials in Oncology·N/A·NCT00091247·130 enrolled

Breast Cancer1 trial

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

Withdrawn·SSWOG Cancer Research Network··NCT00873808

MALT lymphoma1 trial

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00002682·5 enrolled

Lymphoma1 trial

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

Completed·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 2·NCT00003151·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for tetracycline hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — tetracycline hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for tetracycline hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — European Organisation for Research and Treatment of Cancer - EORTC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: EEuropean Organisation for Research and Treatment of Cancer - EORTC

tetracycline hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Skin rash1 trial

Breast Cancer1 trial

MALT lymphoma1 trial

Lymphoma1 trial

References

Drug Info

Quick Facts

Related News